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Abstract
The Ro1 model of hydrocephalus represents an excellent model for studying the pathogenesis of hydrocephalus due to its
complete penetrance and inducibility, enabling the investigation of the earliest cellular and histological changes in
hydrocephalus prior to overt pathology. Hematoxylin and eosin staining, immunofluorescence and electron microscopy
were used to characterize the histopathological events of hydrocephalus in this model. Additionally, a broad battery of
behavioral tests was used to investigate behavioral changes in the Ro1 model of hydrocephalus. The earliest histological
changes observed in this model were ventriculomegaly and disorganization of the ependymal lining of the aqueduct of
Sylvius, which occurred concomitantly. Ventriculomegaly led to thinning of the ependyma, which was associated with
periventricular edema and areas of the ventricular wall void of cilia and microvilli. Ependymal denudation was subsequent
to severe ventriculomegaly, suggesting that it is an effect, rather than a cause, of hydrocephalus in the Ro1 model.
Additionally, there was no closure of the aqueduct of Sylvius or any blockages within the ventricular system, even with
severe ventriculomegaly, suggesting that the Ro1 model represents a model of communicating hydrocephalus.
Interestingly, even with severe ventriculomegaly, there were no behavioral changes, suggesting that the brain is able to
compensate for the structural changes that occur in the pathogenesis of hydrocephalus if the disorder progresses at a
sufficiently slow rate.
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Introduction
Hydrocephalus is a highly prevalent disorder that accounts for
greater than 0.6% of the hospital admissions in the United States,
and health care costs related to hydrocephalus cost the U.S. $1.4–
2.0 billion annually [1]. Despite its prevalence, the primary
treatment for hydrocephalus—the placement of shunts to drain
the excess cerebrospinal fluid (CSF)—has not been significantly
improved in over fifty years. Moreover, these shunts have a high
failure rate—more than two-thirds of shunts fail within a ten-year
period [2,3]. As a result, it is clear that better treatments, such as
drug-based therapeutics, are necessary to treat patients with
hydrocephalus. However, to create novel treatments for hydro-
cephalus and to improve the early diagnosis of this disorder, a
better understanding of the pathogenesis and underlying causes of
hydrocephalus are necessary.
Although the prevalence of congenital hydrocephalus is approx-
imately 0.4–0.8 in 1000 live births, our understanding of the genetic
causes of hydrocephalus is extremely limited [4–7]. Therefore, the
study of genetic animal models of hydrocephalus will likely improve
our understanding of the underlying causes and pathogenesis of
congenital hydrocephalus and may lead to drug-based therapeutics
to treat this disorder. Many genetic animal models for studying
hydrocephalus have been developed, including both models of
communicating and non-communicating hydrocephalus. Non-
communicating hydrocephalus results from a blockage within the
ventricular system. In contrast, in communicating hydrocephalus,
the passages of the ventricular system remain patent.
Among the first the genetic animal models developed was the
hydrocephalus Texas (H-Tx) rat, which was created through
spontaneous genetic mutations and has a penetrance of approx-
imately 40% [8]. Previous studies have demonstrated stenosis of
the aqueduct of Sylvius in H-Tx rats, suggesting that this is a
model of non-communicating hydrocephalus [9,10]. In contrast,
Hy3 mice show defective CSF reabsorption, resulting in
communicating hydrocephalus with perinatal onset [11,12]. In
both of these models, loss of the ependymal cells that line the
lateral ventricles appears to be the result of ventricular
enlargement; as the ventricles enlarge, the ependyma stretches
and denudes [13,14]. The hydrocephalus with hop gait (hyh)
mouse model has also been widely described [15–20]. This non-
communicating model of hydrocephalus displays aqueductal
stenosis, and the development of hydrocephalus in this model
appears to be dependent on ependymal denudation [16,17,19,20].
However, all of these models either have incomplete penetrance or
concomitant pathologies unrelated to hydrocephalus. As a result, it
has been impossible to specifically investigate the pathogenesis of
hydrocephalus using a genetic animal model.
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of hydrocephalus based on the Ro1 RASSL (receptor activated
solely by a synthetic ligand) [21]. The Ro1 receptor is a transgenic
Gi-coupled G protein-coupled receptor (GPCR), which was
developed by mutating the kappa opioid receptor (KOR) [22].
The Ro1 receptor no longer responds to endogenous ligands. We
used a tetracycline-inducible system to drive Ro1 expression
selectively to astrocytes by crossing two single-transgenic lines of
mice: one line expresses the tetracycline transactivator (tTA)
driven by the glial fibrillary acidic protein (GFAP) promoter, and
the other line uses the tetO minimal promoter to drive Ro1
expression. Upon the removal of doxycycline (dox) from the
drinking water of double-transgenic KOR knockout mice, tTA
binds to the tetO promoter, driving Ro1 expression. Interestingly,
we found that when mice are taken off dox, 100% of double-
transgenic mice develop hydrocephalus [21]. Additionally, we
have demonstrated using immunohistochemistry that the Ro1
receptor co-localizes with astrocyte-specific, but not neuron-
specific, markers [21], and data from our laboratory have
demonstrated that the Ro1 receptor is also expressed in
ependymal cells [23]. Thus, basal levels of Ro1 receptor activity
in astrocytes and ependymal cells are enough to cause hydro-
cephalus in double-transgenic Ro1 mice. The high basal activity
levels and high levels of Ro1 expression are likely sufficient to
stimulate aberrant GPCR signaling in astrocytes, leading to
hydrocephalus. Interestingly, selective expression of the Ro1
receptor in the mouse heart causes lethal cardiomyopathy [24],
and its expression in osteoblasts causes trabecular osteopenia [25],
both of which are solely due to the basal levels of activity of the
Ro1 receptor.
To our knowledge, the Ro1 model is the first model of
hydrocephalus to implicate aberrant GPCR signaling in the
pathogenesis of this disorder. Additionally, by targeting the Ro1
receptor selectively to GFAP-positive cells (astrocytes and
ependymal cells), we have developed a novel model of commu-
nicating hydrocephalus in which a single signaling system in a
specific cell type leads to hydrocephalus. Thus, due to its
inducibility, 100% penetrance and cell-specific, signaling-mediat-
ed pathogenesis, the Ro1 model is unique in that it enables the
investigation of the early histological, behavioral and signaling
events that cause hydrocephalus, without complications from
secondary pathologies. The Ro1 model therefore enables
researchers to investigate the etiology of hydrocephalus, rather
than being restricted to studying pathological changes subsequent
to overt hydrocephalus. Findings from the Ro1 model may
therefore lead to the development of drug-based therapeutics to
treat this disorder. In this study, we used a combination of
histology, immunohistochemistry, electron microscopy and be-
havior to elucidate the histological and behavioral changes that are
occur as hydrocephalus progresses.
Materials and Methods
Animals
This study was conducted in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals at the National Institutes of Health. All of
the experiments were approved by the Institutional Animal Care
and Use Committee at the University of North Carolina at Chapel
Hill under protocol number 09-096. Animals were maintained in
climate-controlled housing with a 12 h light/dark cycle and were
given food and water ad libitum. Selected breeding pairs and
weaned mice were given 50 mg/mL doxycycline (dox; Sigma-
Aldrich, St. Louis, MO) in their drinking water, which was
changed twice a week. Dox was provided in black water bottles to
protect the dox from light. Breeding pairs maintained off dox were
never exposed to dox.
Transgenic mice
GFAP-tTA::tetO-Ro1 mice on a KOR knockout background
were generated as described previously [21]. All of the mice were
backcrossed onto the C57Bl/6J background (10 generations).
Real-time PCR
Two 1 mm thick coronal brain sections at the level of the lateral
ventricles from six single-transgenic control and six double-
transgenic Ro1 mice at 9 days off dox, were sliced on an acrylic
matrix and placed in RNA later (Ambion, Austin, TX) at 220uC.
RNA was isolated using the RNeasy Lipid Tissue Mini Kit
(Qiagen, Valencia, CA), and the amount of RNA per sample was
quantified using a NanoDrop spectrophotometer (Thermo Fisher
Scientific, Waltham, MA). RNA from each mouse was sent for an
RNA quality check at the Nucleic Acids Core Facility at the
University of North Carolina at Chapel Hill. cDNA was then
prepared using Superscript II Reverse Transcriptase with random
primers and RNaseIn to block RNase activity (Ambion, Austin,
TX). Real-time PCR was conducted using hKOR2 and GAPDH
primers and a TaqManH Universal PCR Master Mix (Applied
Biosystems, Foster City, CA). Fold enrichment was determined
using the 2
2DCT method, and the data are presented as the
enrichment of Ro1 expression relative to the lowest expresser.
Hematoxylin and eosin staining
Single-transgenic controls and double-transgenic Ro1 mice
were taken off dox at P30 and transcardially perfused with 4%
paraformaldehyde at 9 (controls, n=4; Ro1, n=4), 12 (controls,
n=7; Ro1, n=7), 18 (controls, n=6; Ro1, n=6), 24 (controls,
n=6 controls; Ro1, n=6), 30 (controls, n=5; Ro1, n=5) and 48
days (controls, n=21; Ro1, n=17) following dox removal. This
wide range of time points was chosen to analyze changes in
hydrocephalus beginning shortly after Ro1 receptor expression
through overt hydrocephalus and moribundity. To study the effect
of Ro1 expression throughout gestation and development, dams
were maintained off dox, and weaned mice were perfused at P27
(controls, n=6; Ro1, n=6). Following perfusion, the brains were
removed and post-fixed overnight at room temperature in 10%
formalin with gentle agitation. The brains were then rinsed in
distilled water and stored in 70% ethanol. The brains were taken
to the University of North Carolina at Chapel Hill histology core
facility for paraffin embedding. Serial coronal sections were sliced
5 mm thick on a sliding microtome (Leica, Wetzlar, Germany) and
stained with hematoxylin and eosin. Stained brain sections were
imaged with a light microscope (Zeiss, Oberkochem, Germany),
and images were captured using a Dage Excel XL16 camera
(Dage-MTI, Michigan City, IN).
Measurements
Images from hematoxylin and eosin stained coronal brain
sections from both single-transgenic controls and double-trans-
genic Ro1 mice at 0.38 mm anterior to bregma were analyzed
with MetaMorph image analysis software (Molecular Devices,
Sunnyvale, CA). The maximum width of the lateral ventricles was
measured and divided by the maximum brain width to obtain the
lateral ventricle to brain ratio (LV:brain ratio). For measurements
of ependymal disorganization at the aqueduct, images of the
aqueduct of Sylvius were captured from both control and Ro1
mice at 18, 24, 30 and 48 days off dox immediately posterior to the
Pathogenesis of Hydrocephalus in a Novel Model
PLoS ONE | www.plosone.org 2 January 2012 | Volume 7 | Issue 1 | e30159dorsal third ventricle (approximately 2.92 mm posterior to
bregma). Ependymal disorganization was defined as the displace-
ment or loss of the ependymal cells lining the aqueduct and their
cilia and was scored by three observers blind to genotype based on
the continuity of the ependyma and the degree of cilia coverage. A
four-point scoring system was used to classify the aqueductal
ependyma as (3) normal, representing a continuous ependymal
lining and a dense, continuous carpet of cilia, (2) mild, suggesting
minimal ependymal and cilia loss, (1) moderate, representing
considerable ependymal and cilia loss, or (0) severe, which
represented almost complete loss of ependymal cells and their
associated cilia.
Immunohistochemistry
Single-transgenic controls and double-transgenic Ro1 mice
were taken off dox at P30 and transcardially perfused with 4%
paraformaldehyde at 9 (controls, n=4; Ro1, n=4), 12 (controls,
n=3; Ro1, n=3) and 24 days (coronal: controls, n=5; Ro1, n=5;
sagittal: controls, n=5; Ro1, n=5) after the removal of dox.
These time points were chosen to observe changes in the
subventricular zone (SVZ) early in the pathogenesis of hydro-
cephalus to determine whether changes in this region play a
causative role in the development of hydrocephalus in the Ro1
model. The brains were post-fixed for 4 h in 4% paraformalde-
hyde at 4uC and subsequently transferred to a 30% sucrose
solution in PBS (pH 7.4) at 4uC for cryoprotection. The brains
were then embedded and frozen in O.C.T. (Optimal Cutting
Temperature; Tissue-Tek, Sakura, Japan) in an ethanol/dry ice
bath and stored at 280uC. Ten micrometer thick coronal and
sagittal slices were cut on a cryostat (Leica, Wetzlar, Germany) and
melted onto Superfrost Plus slides (Thermo Fisher Scientific,
Waltham, MA). The slices were washed three times with
phosphate buffered saline (PBS) and incubated in blocking solution
(10% normal goat serum and 0.3% TritonX-100 in PBS). The
slices were then incubated in primary antibody in blocking
solution overnight at 4uC. The primary antibodies used were
doublecortin (DCX, 1:500; Cell Signaling, Beverly, MA) to stain
for migrating neuroblasts, glial fibrillary acidic protein (GFAP,
1:500; Sigma-Aldrich, St. Louis, MO) to stain for astrocytes and
S100 (1:500; DAKO, Carpenteria, CA) to stain for ependymal
cells. The slices were then washed six times for 10 min in PBS and
incubated in goat anti-rabbit 594 or goat anti-mouse 488
secondary antibodies (Alexa Fluor, 1:400; Invitrogen, Carlsbad,
CA) in blocking solution for 2 h at room temperature. The slices
were washed six times for 10 min in PBS and mounted in
Vectashield with DAPI (Vector Laboratories, Burlingame, CA),
coverslipped and sealed with nail polish. The sections were imaged
with a fluorescent microscope (Zeiss, Oberkochem, Germany).
Electron microscopy
Single-transgenic controls and double-transgenic Ro1 mice
were taken off dox at P30 and transcardially perfused at 18
(controls, n=8; Ro1, n=8) and 30 days (controls, n=4; Ro1,
n=4) off dox with Ringer’s solution (1.36 M NaCl, 0.127 M
Na2HPO4, 0.503 M KCl, 0.098 M MgCl2, 0.595 M NaHCO3,
0.204 M CaCl2 and 2.2 mM dextrose, with 0.004% xylocaine to
anesthetize smooth muscle and 5 U/mL heparin to prevent blood
clotting) followed by 2% paraformaldehyde and 2.5% glutaralde-
hyde in 0.1 M phosphate buffer for 10 min at a rate of 3 mL/min.
These two time points were chosen to investigate the ultrastruc-
tural changes immediately prior to ventriculomegaly (18 days off
dox) and those present with mild to moderate ventriculomegaly
(30 days off dox). The brains were post-fixed in the same fixative
for 1 h on ice and sliced 50 mm thick on a Vibratome (Leica,
Wetzlar, Germany) in ice-cold fixative. The tissue slices were then
post-fixed overnight in the same fixative at 4uC. The sections were
subsequently post-fixed in 0.5% osmium tetraoxide in 0.1 M
phosphate buffer for 45 min and stained with 1% uranyl acetate in
maleate buffer for 45 min. After dehydrating in an ascending
ethanol series, the sections were embedded in Epon/Spurr resin
(Electron Microscopy Services, Hatfield, PA) and mounted
between sheets of Aclar within glass slides. After embedding, the
sections were cut 60 nm thick on an Ultracut (Leica, Wetzlar,
Germany), mounted onto T200 copper grids (Electron Microscopy
Services, Hatfield, PA) and post-stained with 2% uranyl acetate
and Sato’s lead.
Behavior
To investigate progressive changes in weight and general motor
ability, mice (controls, n=11; Ro1, n=10) were taken off dox at
P30, and weight, grip strength (wire hang), motor coordination
(rotarod), exploratory behavior (open field) and startle responses
and sensorimotor gating (acoustic startle) were measured imme-
diately following the removal of dox and every week thereafter for
a total of seven weeks to evaluate the behavioral changes that may
occur as hydrocephalus develops. For the wire hang test, the mice
were placed, one at a time, on a wire grid and inverted
approximately 20 cm above a soft sponge. The latency to fall off
of the grid was recorded; the maximum cut-off time was 60 s. For
the rotarod test, the mice were placed on an accelerating cylinder
(rotarod), and the latency to fall off of the rotarod was recorded;
the maximum cut-off time was 300 s. The mice were first given a
series of three trials to evaluate motor learning; on each
subsequent testing day, the mice were given two trials on the
accelerating rotarod to measure motor coordination. For the open
field test, the mice were placed in a large plexiglas enclosure with a
photobeam array (Accuscan Instruments, Columbus, OH) and
allowed to freely explore for 1 h. Total distance traveled (cm),
horizontal activity, stereotypy counts and rearing activity were
measured. For the acoustic startle test, the SR-LAB startle
response system was used (San Diego Instruments, San Diego,
CA). Briefly, the mice were placed in a Pplexiglas cylinder with
white noise at a level of 70 dB. The mice were given a loud startle
(120 dB) or a prepulse (74, 78, 82, 86 or 90 dB) followed by the
loud startle (120 dB), and the force displaced by a whole-body
startle response was measured by an accelerometer. Responses to
the startle alone or the prepulse followed by the startle were
randomized; the response to each stimulus was tested six times
with 15 s between stimuli.
A second cohort of mice (control, n=10; Ro1, n=11) was used
to test learning and memory in the Morris water maze. The
Morris water maze consists of a circular pool (diameter=122 cm)
partially filled with water (45 cm deep, 24–26uC) containing non-
toxic white paint. The pool was visually divided into four
quadrants. Visual cues were placed in the room surrounding the
pool. Visual learning was tested at 10–12 days after removal of dox
by placing the mice in the pool and measuring their latency to
swim to a visible platform. Learning acquisition of the location of a
hidden platform (diameter=12 cm) was then tested until the
average latency of the mice was less than 15 s. This test was
conducted from 15–19 days off dox by placing the escape platform
below the surface of the water and measuring their latency to learn
the location of the hidden platform based on the visual cues in the
surrounding room. A probe trial was then conducted at 19 days off
dox by measuring the time spent in each of the quadrants;
increased time spent swimming in the quadrant where the
platform had been previously located (quadrant 1) was considered
indicative of learning. The platform was then moved to the
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new location of the platform was measured. The mice were trained
in the reversal learning paradigm until the latency to find the
hidden platform was, on average, less than 15 s. Reversal learning
occurred from 22–32 days off dox, and the probe trial for reversal
learning was conducted at 32 days off dox. The mice were then
tested for the ability to remember the location of the hidden
platform (quadrant 3) by recording their latency to find the
platform at 46–47 days off dox (retention). This test was scheduled
such that changes in learning and memory (hidden and reversal
tests) were evaluated prior to ventriculomegaly through the
development of ventriculomegaly. The retention test was timed
to evaluate changes in memory with severe ventriculomegaly.
A third group of mice (control, n=17; Ro1, n=13) was used to
test the development of anxiety and depression in early
hydrocephalus. At 24 days off dox, at which point minimal to
mild ventriculomegaly is present in Ro1 mice, the mice were tested
on the elevated plus maze, which has two open arms and two
closed arms (20 cm in height). The maze is elevated 50 cm from
the floor and the arms are 30 cm long. The mice were placed in
the center section (8 cm68 cm) and allowed to freely explore the
maze. The time spent in the open and closed arms and the
number of entries into each of the arms was recorded. The mice
were subsequently tested in the forced swim test at 25 days off dox.
In this test, the mice were placed in a cylinder (28 cm high;
20.2 cm in diameter) filled with water (14.5 deep; 23uC), and their
time spent immobile in a 6 min period was recorded. The time
spent in the center of the open field apparatus (AccuScan
Instruments, Columbus, OH) in 1 h was used as a measure of
anxiety in mice 31 days off dox. Lastly, passive avoidance was
tested in mice 32–33 days off dox. The passive avoidance test
consisted of two trials. On the first day of testing, the mice were
placed in the apparatus, which consists of a light chamber and a
dark chamber, separated by a door. After a 30 s acclimation
period, the door is opened, and when the mice enter the dark
chamber, they receive a mild footshock (0.5 mA, 2 s). On the
second day of testing, the latency to enter the dark chamber was
measured; a 300 s cut-off was used. Based on histological findings,
these final two tests were timed to investigate changes in Ro1 mice
off dox with mild to moderate ventriculomegaly.
Statistics
For comparisons between control and Ro1 mice at a single time
point, Student’s t-test was used. To analyze changes in the
behavioral tests over time as well as changes in the acoustic startle
test, repeated-measures ANOVAs were used. For the rotarod and
wire hang tests, which were not normally distributed, the Mann
Whitley test with the Bonferroni correction was used to compare
changes at each time point. An F-test was used to calculate a p-
value for the linear regression analyses. P-values,0.05 were
considered to be statistically significant. StatView statistical
software (version 5.0) was used for all of the statistical tests (SAS,
Cary, NC).
Results
Ventriculomegaly and disorganization of the aqueduct of
Sylvius are the first signs of pathology in the Ro1 model
Although there was clear, but variable, Ro1 receptor expression
in the double-transgenic mice by 9 days off dox (Figure 1; n=6),
there were no detectable morphological changes in these mice at 9,
12 or 18 days off dox. Ventriculomegaly was first observed in the
Ro1 mice at 24 days off dox (Figure 2). However, likely due to the
variability observed in Ro1 receptor expression among the double-
transgenic mice, there was considerable variability in ventricle size
among the Ro1 mice at this time point (average LV:brain
ratio=0.22; range=0.14–0.39). Ventriculomegaly was more
pronounced in the Ro1 mice at 30 and 48 days off dox
(Figure 2), with an average LV:brain ratio of 0.25 at 30 days
(range=0.15–0.43) and 0.38 at 48 days (range=0.18–0.64).
Concomitant with the increase in ventricle size, disorganization
of the ependymal cells and their cilia was observed at the aqueduct
Figure 1. Variable expression of the Ro1 receptor in Ro1 mice at 9 days off doxycycline. This graph shows the relative quantification of
Ro1 receptor expression in Ro1 mice and age-matched littermate controls (n=6). Each sample was run in triplicate, and the error bars show the
variability in detected Ro1 expression for each mouse, with the positive error bar representing the maximum value and the negative error bar
representing the minimum value. Although the Ro1 receptor was clearly expressed by Ro1 mice by 9 days after removal of dox at P30, there was
considerable variability in the levels of expression among Ro1 mice.
doi:10.1371/journal.pone.0030159.g001
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aqueduct was highly correlated with the severity of ventriculome-
galy, as measured by the lateral ventricle to brain ratio (r
2=0.78;
p=6.15 * 10
29; Figures 2 and 3). However, complete closure of
the aqueduct of Sylvius was never observed.
Ependymal denudation of the lateral ventricles is
secondary to ventriculomegaly
Ependymal denudation of the lateral ventricles often accompa-
nies enlargement of the lateral ventricles in humans and other
animal models. Interestingly, when taken off dox at P30, the brains
from the Ro1 mice rarely showed denudation; denudation was
only present at the dorsal surface of the lateral ventricle with
severe ventriculomegaly. However, the ependymal lining became
thinner across the dorsal, medial and lateral walls of the lateral
ventricles with increasing lateral ventricle size (Figure 2). The
thinning of the ependymal lining observed at the lateral ventricles
differed from the considerable ependymal cell loss and displace-
ment observed at the aqueduct of Sylvius.
Despite ventriculomegaly, there is no change in
subventricular zone organization in early hydrocephalus
Because Ro1 expression is being driven to GFAP-positive cells
and GFAP is expressed in both subventricular zone (SVZ)
astrocytes and at low levels in ependymal cells [23,26], we
hypothesized that Ro1 expression might be affecting SVZ
organization. Furthermore, SVZ astrocytes extend processes that
both integrate into the ependymal layer and contact blood vessels
[27], positioning them to play a potential role in ventriculomegaly
and ependymal denudation in hydrocephalus. These SVZ
astrocytes are also the progenitor cells of the SVZ, giving rise to
neuroblasts that migrate to the olfactory bulb where they form
olfactory interneurons [28–30]. Moreover, astrocytes direct the
migration of the SVZ-born neuroblasts [31–33]. To determine
Figure 2. Histopathological changes in the pathogenesis of
hydrocephalus in the Ro1 model. Double-transgenic Ro1 mice and
age-matched littermate controls were taken off dox at P30 and analyzed
at 9 (n=4),12 (n=7),18 (n=6),24 (n=6),30 (n=5)and48 days (controls,
n=21; Ro1, n=17) off dox to investigate histopathological changes in
the pathogenesis of hydrocephalus in the Ro1 model. Images of coronal
brain slices (A, D and G; scale bar=1.0 mm), the dorsolateral wall of the
left lateral ventricle (B, E and H; scale bar=75 mm) and the aqueduct of
Sylvius(C,F andI; scale bar=50 mm) areshown from a controlmouse (A–
C; 24 days off dox) and two Ro1 mice (D–F and G–I, 24 and 48 days off
dox, respectively). The Ro1 mice showed progressive enlargement of the
lateral ventricles (D and G), thinning (E and H) of the ependymal layer of
the lateral ventricles and disorganization of the ependymal lining of the
aqueduct of Sylvius (F and I).
doi:10.1371/journal.pone.0030159.g002
Figure 3. Lateral ventricle size correlates with the degree of ependymal disorganization at the aqueduct of Sylvius. The lateral
ventricle size of Ro1 mice is significantly correlated to disorganization of the ependymal cells at the aqueduct of Sylvius (r
2=0.78; p=6.15 * 10
29). A
four-point scoring system was used to classify the aqueductal ependyma as (3) normal, representing a continuous ependymal lining and a dense,
continuous carpet of cilia, (2) mild, suggesting minimal ependymal and cilia loss, (1) moderate, representing considerable ependymal and cilia loss, or
(0) severe, which represented almost complete loss of ependymal cells and their associated cilia. As a reference, panel F of Figure 2 was scored as
moderately disorganized (1), whereas panel I of Figure 2 was scored as severely disorganized (0). As lateral ventricle size increased (an increase in the
lateral ventricle to brain ratio), the aqueduct became increasingly disorganized.
doi:10.1371/journal.pone.0030159.g003
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organization and neuroblast migration early in the pathogenesis of
hydrocephalus, coronal and sagittal slices were stained for cellular
markers of the SVZ. Although there was lateral ventricle
enlargement and thinning of the ependymal layer in mice at 24
days off dox, there were no qualitative changes in the staining of
astrocytes or ependymal cells between the Ro1 mice and age-
matched, single-transgenic controls at 9 (n=4), 12 (n=3) or 24
days (n=5) off dox (Figure 4A–F). Additionally, sagittal slices
stained with DCX showed no qualitative changes in the number
or migration of SVZ-born neuroblasts between Ro1 mice and age-
matched, single-transgenic controls at 12 (data not shown; n=3)
or 24 days (n=5) off dox (Figure 4G–H).
Ventriculomegaly leads to thinning of the ependymal
layer, which is associated with edema and patches of the
ventricular wall barren of cilia and microvilli
Because no gross morphological changes were observed with
either H&E staining or immunohistochemistry, transmission
electron microscopy (TEM) was performed to investigate the
ultrastructure of the ependymal and subependymal layers of the
lateral ventricles of Ro1 mice early in the development of
hydrocephalus. No changes were observed in the Ro1 mice at
18 days off dox, as compared to age-matched littermate controls,
which corroborates the findings from the light microscopy
experiments (data not shown; n=8). However, at 30 days off
dox (n=4), considerable thinning of the ependymal layer was
observed, as compared to age-matched littermate controls
(Figure 5). Additionally, there were patches of the lateral ventricle
walls that were barren of cilia and microvilli (Figure 5). A
considerable number of vacuoles was present in the ependymal
cells of the hydrocephalic mice (Figure 5). Pockets of edematous
fluid were also present in the periventricular area (Figure 5).
Mice maintained off dox show similar disease
progression to mice taken off dox at P30
To investigate whether Ro1 expression throughout gestation
and development alters disease progression in double-transgenic
mice, dams were never given dox, and both Ro1 and single-
transgenic littermate control pups were maintained off dox until
perfusion at P27 (n=4). Double-transgenic Ro1 mice showed
severely enlarged heads at P27 (data not shown). Histological
analysis using H&E staining showed severe but variable ventricu-
lomegaly in the Ro1 mice (Figure 6). Ependymal denudation was
only present at the roof of the lateral ventricle in Ro1 mice with
severely enlarged lateral ventricles. Additionally, despite analysis of
serial coronal sections from the third ventricle through the fourth
ventricle, complete closure of the aqueduct of Sylvius was never
observed even in the most severely hydrocephalic brains studied,
although disorganization of the ependymal lining of the aqueduct
was present in all of the Ro1 mice with ventriculomegaly (Figure 6).
Behavioral changes are mostly absent in Ro1 mice
despite ventriculomegaly
To our surprise, no changes in weight or motor ability were
observed in the Ro1 mice over seven weeks of testing (Table 1;
control, n=11; Ro1, n=10). Subsequent perfusion and histolog-
ical analysis of the brains of these mice showed moderate to severe
ventriculomegaly (LV:brain ratio .0.3) in 67% of the mice at
week 7. However, there were no correlations between lateral
ventricle size and behavioral changes for any of the motor tests
(data not shown). Weight dropped off precipitously a couple of
days prior to death. There were also no significant changes in the
performance of the Ro1 mice in the Morris water maze (Table 2;
control, n=11; Ro1, n=10); however, there was a moderate
correlation (r
2=0.59; p=0.026) between lateral ventricle size and
the latency to find the hidden platform in the retention test at 46
days off dox (Figure 7). Additionally, there were no significant
changes in any of the behavioral tests measuring anxiety or
depression (Table 3; control, n=17, Ro1, n=13).
Discussion
In this study, we show that selectively expressing the transgenic
Ro1 receptor in astrocytes using a tetracycline-inducible system
results in a novel and inducible model of hydrocephalus that can
be used to study the etiology and the pathogenesis of this disorder.
Figure 4. Lack of cellular changes in subventricular zone
organization in early hydrocephalus in Ro1 mice. (A) and (B)
show GFAP (green) and S100 (red) expression at 9 days off dox in
control and Ro1 mice, respectively (n=4; scale bar=50 mm). (C) and (D)
show GFAP (green) and S100 (red) expression at 12 days off dox in
control and Ro1 mice, respectively (n=3; scale bar=100 mm). (E) and (F)
show GFAP (green) and S100 (red) expression at 24 days off dox of
control and Ro1 mice, respectively (n=5; scale bar=200 mm). These
images were taken from the right lateral ventricle in coronal slices.
There were no qualitative changes in GFAP or S100 expression at any
time point analyzed. (G) and (H) show DCX (red) expression from the
lateral ventricle to the olfactory bulb in sagittal sections from control
and Ro1 mice, respectively, at 24 days off dox. There were no qualitative
changes in DCX expression or migration at 24 days off dox (n=5; scale
bar=100 mm).
doi:10.1371/journal.pone.0030159.g004
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study demonstrates that ventriculomegaly and disorganization of
the ependyma lining of the aqueduct of Sylvius are the earliest
morphological changes observed in the pathogenesis of hydro-
cephalus in the Ro1 model. Ventricular ependymal denudation
and cilia loss, a common feature of hydrocephalus in humans and
animal models, appear to result from enlargement of the lateral
ventricles. This finding suggests that ventricular ependymal loss
and cilia dysfunction are not a cause of hydrocephalus but rather
due to the resulting pathology. Furthermore, complete closure of
the aqueduct of Sylvius, the narrowest part of the ventricular
system, was never observed. Additionally, no obstructions were
present in the ventricular system, suggesting that the Ro1 model
represents a model of communicating hydrocephalus. It is
interesting that although the aqueduct never closed, disorganiza-
tion of the ependyma of the aqueduct was observed. The
mechanism leading to the disorganization of the aqueduct as well
as the role of this disorganization in the pathogenesis of
hydrocephalus remain unclear. Previous studies have suggested
that aqueductal stenosis alone may cause ventriculomegaly, and
studies in the hyh mouse model of hydrocephalus have
demonstrated that the onset of severe hydrocephalus is associated
with aqueductal stenosis caused by the failure of the subcommis-
sural organ to form a normal Reissner’s fiber [17,34]. Although
closure of the aqueduct was never observed in this study and is
therefore not the cause of hydrocephalus in the Ro1 model, it is
possible that the loss of ependymal cells and cilia in the aqueduct
in our model may cause hydrocephalus by affecting the bulk flow
of CSF through the aqueduct, but further studies are necessary to
investigate this possibility.
These histological changes observed in Ro1 model of hydro-
cephalus appear to mirror human hydrocephalus in many
respects. Multiple studies have suggested that ependymal denuda-
tion is subsequent to ventriculomegaly and the degree of
denudation appears to be dependent on the size of the lateral
ventricles and that the rate at which hydrocephalus progresses;
more rapid disease progression leads to increased ependymal loss
[35–38]. We also observed increased ependymal denudation and
cilia loss with increasing ventricular size and a correlation between
the rate of hydrocephalus development and both denudation and
cilia density. Whereas considerable denudation and loss of cilia
was found in P27 mice maintained off dox throughout gestation
and development, denudation was rarely observed in Ro1 mice
taken off dox at P30, even with severe ventriculomegaly. These
Figure 5. Ultrastructural changes in the periventricular region
in Ro1 mice. Ventriculomegaly leads to thinning of the ependymal
layer, which was associated with edema and patches of the ventricular
wall barren of cilia and microvilli. An age-matched littermate control (A)
and two Ro1 (B and C) mice at 30 days off dox are shown (controls,
n=4; Ro1, n=4). Ro1 mice showed considerable thinning of the
ependymal layer and a reduction in the number of microvilli lining the
ventricles (black arrows). In the Ro1 mouse with an enlarged head and
moderate ventriculomegaly (B), spaces appear to be developing
between cells (white arrows). In the Ro1 mouse with a severely
enlarged head and severe ventriculomegaly (C), vacuoles were present
in the ependymal cell cytoplasm, and edema was present in the
periventricular tissue (EF=edematous fluid). These images were taken
from the lateral wall of the lateral ventricle. Scale bar=2 mm.
doi:10.1371/journal.pone.0030159.g005
Figure 6. Morphological changes in the progression of
hydrocephalus in mice maintained off dox. The progression of
hydrocephalus in mice maintained off dox throughout gestation and
development mirrors that found in mice taken off dox at P30. Images of
coronal brain slices (A, D and G; scale bar=1.0 mm), the dorsolateral
wall of the left lateral ventricle (B, E and H; scale bar=75 mm) and the
aqueduct of Sylvius (C, F and I; scale bar=50 mm) are shown from a
control mouse (A–C) and two Ro1 mice (D–F and G–I) at P27. The Ro1
mice showed variable enlargement of the lateral ventricles (D and G),
thinning (E) or loss (H) of the ependymal layer at the lateral ventricles
and disorganization of the ependymal lining of the aqueduct (F and I).
The average LV:brain ratio was 0.34, and the range=0.18–0.64. (n=4).
doi:10.1371/journal.pone.0030159.g006
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hydrocephalus occurs more slowly when hydrocephalus is induced
by the removal of dox in young adults; this may provide the
ependyma with greater time to compensate for the enlargement of
the ventricles, thereby reducing the degree of denudation
observed.
Interestingly, thinning of the ependymal layer due to ventricu-
lomegaly appears to lead to edema and a loss of microvilli lining
the walls of the lateral ventricles. Previous TEM studies in the hy3
mouse model and in a rabbit with kaolin-induced hydrocephalus
have also shown stretching of the ependymal layer, intact but
widely separated clusters of cilia and microvilli and edematous
tissue with enlarged extracellular spaces, which mirrors the results
obtained in our study [37,39]. The variable loss of microvilli and
the degree of edema in our model at 30 days off dox is likely due to
the highly variable rate of disease progression in these mice; a
greater degree of ventriculomegaly was associated with increased
edema and loss of microvilli. Studies have suggested that fluid
accumulation in the periventricular region, which has been termed
periventricular edema, is a result of transependymal flow of CSF
due to the loss of tight junctions between the ependymal cells
caused by ventriculomegaly [37,40,41]. Our TEM data demon-
strating intracellular spaces between cells in mice with moderate
hydrocephalus and subsequent periventricular edema in mice with
severe hydrocephalus support this idea.
Subependymal gliosis is also commonly observed in humans
and animals with chronic hydrocephalus. However, subependymal
gliosis has been shown to be subsequent to ependymal loss [36,37].
Additionally, other studies in the H-Tx rat model of congenital
hydrocephalus have suggested that ventricular dilation and
increased intracranial pressure serve as triggers for gliosis around
the periventricular and periaqueductal regions [42,43]. Thus, it is
perhaps unsurprising that we did not observe gliosis early in the
pathogenesis of hydrocephalus in Ro1 mice, despite the mild
ventriculomegaly present in the Ro1 mice at 24 days off dox.
However, a previous study has demonstrated gliosis in the
hippocampus and cortex of severely hydrocephalic Ro1 mice
[21], suggesting that gliosis occurs in Ro1 mice following severe
ventricular dilation. Although changes in the subventricular zone
of human fetuses with moderate communicating hydrocephalus
have also been observed, these changes were shown to be
subsequent to ventricular dilation and ependymal loss [44].
Therefore, it is possible that SVZ disorganization is also present
in Ro1 mice, but only in mice with severe hydrocephalus and
ependymal denudation.
Surprisingly, there were no behavioral changes observed in the
pathogenesis of hydrocephalus in the Ro1 model, even when
severe ventriculomegaly was present. Although we were surprised
to discover a lack of significant behavioral changes in Ro1 mice
even in the presence of ventriculomegaly, our data are perhaps
unsurprising considering the slow development of hydrocephalus
when Ro1 mice are taken off dox at P30. Del Bigio and colleagues
have suggested that a slower rate of disease progression results in
less severe morphological and behavioral changes and that there is
a threshold of ventricle size beyond which functional changes
appear, which is dependent on various factors, such as age of onset
and rate of ventricular enlargement [45]. The results of previous
Table 1. Changes in weight and general motor ability of Ro1 mice and littermate controls over seven weeks of testing.
a
Week 1 Week 4 Week 7 p-value
Control Ro1 p-value Control Ro1 p-value Control Ro1 p-value (7 weeks)
b
Weight (g) 12.560.5 12.760.5 0.77 18.160.67 17.760.79 0.71 20.360.8 19.760.8 0.67 0.90
Wire hang 58625 6 64 0.94 60605 5 65 0.70 60605 1 67 0.36 NA
c
(latency, s)
Rotarod 219627 229623 .0.99 287672 3 2 631 0.26 259618 250624 0.90 NA
c
(latency, s)
Total distance 57906563 58166411 0.97 781761144 60456901 0.25 857361051 1181762189 0.16 0.62
(cm)
Startle response 615.8658.4 520.9620.7 0.18 970.56113.3 899.2694.3 0.65 862.1698.6 814.36102.0 0.75 0.23
(to 120 dB)
Ro1, n=10; Control, n=11.
aWeeks 1, 4 and 7 are shown for simplicity. There were also no significant changes at weeks 2, 3, 5 or 6.
bStudent’s t-test was used to measure differences between Ro1 and control mice at each week; a repeated measures ANOVA was used to measure changes acrossa l l
seven weeks of testing. For the wire hang and rotarod tests, which were not normally distributed, the Mann Whitley test was used to compare differences between the
Ro1 and control mice at each week.
cRepeated measures ANOVAs across all seven weeks of testing were not calculated for the wire hang and rotarod tests because these data were not normally
distributed.
doi:10.1371/journal.pone.0030159.t001
Table 2. Performance of Ro1 mice and littermate controls in
the Morris water maze.
Days off dox Control Ro1 p-value
Hidden platform acquisition 19 14621 1 610 . 6
(latency, trial 4, s)
Hidden probe trial 21 25632 3 62 0.86
(duration quadrant 1, s)
Reversal platform acquisition 32 12621 6 64 0.93
(latency, trial 9, s)
Reversal probe trial 34 14611 9 63 0.17
(duration quadrant 3, s)
Retention 47 18642 6 66 0.26
(latency, trial 1, s)
Ro1, n=10; Control, n=11.
doi:10.1371/journal.pone.0030159.t002
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have shown conflicting results that appear to be dependent on the
severity of hydrocephalus and age of onset. For example, there was
no change in rotarod performance in juvenile or adult mice
injected with kaolin at 7 or 14 days post-injection [46] or in kaolin-
injected neonatal rats at P20, 19 days after kaolin injection [47]. In
contrast, when rats were injected with kaolin to induce
hydrocephalus at three weeks, there was a significant decrease in
rotarod performance at eight months post-injection [45], suggest-
ing that severe hydrocephalus is necessary in the kaolin-injected
model before behavioral changes on the rotarod are apparent.
Further, changes in the Morris water maze test have only been
observed in mice with overt hydrocephalus [48–50]. Interestingly,
Del Bigio et al. (2002) have demonstrated that there is a significant
inverse relationship between ventricle volume and final perfor-
mance in the water maze [48]. These changes mirror those found
in our study: performance in the Morris water maze was not
impaired until severe ventriculomegaly was present. Additionally,
past behavioral studies in H-Tx rats and rats with kaolin-induced
hydrocephalus have suggested that motor activity and body weight
rapidly deteriorate immediately prior to death [49,51]. In our
study, we also found hypoactivity, reduced rotarod performance
and a loss of body weight in mice immediately prior to death. In
humans, gait abnormalities, motor disorders and memory and
cognitive deficits are the most common behavioral changes;
however, these behavioral deficits are associated with overt
hydrocephalus and are likely due to the compression of brain
tissue (e.g., the cortex, hippocampus and cerebellum) that is
common with severe hydrocephalus [52–56].
It is therefore likely that in the Ro1 model, taking the mice off
dox to induce astrocyte-specific Ro1 expression and hydroceph-
alus at P30 results in a slow rate of ventricular enlargement that
reduces the likelihood of observing behavioral changes. It is
possible that compensation is occurring in the brains of these mice,
allowing them to adapt to the gross morphological changes
resulting from ventriculomegaly. Considering that we see more
rapid disease progression in Ro1 mice maintained off dox
throughout gestation and development, it is possible that Ro1
mice taken off dox at a younger age would show a more rapid rate
of ventricular enlargement and behavioral changes.
At this point, it remains unclear how the expression of the Ro1
receptor in GFAP-positive cells, namely astrocytes and ependymal
cells, leads to hydrocephalus in the Ro1 model. The processes of
subependymal astrocytes have been demonstrated to both
integrate into the ependymal lining of the ventricular system and
contact the vasculature, positioning them to play a central role in
the development of hydrocephalus [57]. It is possible that Ro1
expression in astrocytes and ependymal cells affects CSF
production or absorption. For example, aquaporin 4 is a water
channel that is expressed on astrocytes and ependymal cells at the
borders between the brain parenchyma and major fluid compart-
ments, including at astrocyte endfeet, at the glia limitans and at the
brain-ventricular CSF barrier [58,59]. Thus, dysregulation of
aquaporin 4 may alter the normal removal of redundant fluid from
the parenchyma to the ventricular system and subarachnoid space.
Table 3. Assessment of anxiety and depression in Ro1 mice
and littermate controls.
Days off dox Control Ro1 p-value
Elevated plus maze 24 59.564.8 61.564.9 0.78
(open arm time, s)
Forced swim test 25 81.6612.5 74.568.7 0.66
(time immobile, s)
Open field 31 19.664.1 25.263.8 0.33
(center time, s)
Passive avoidance 33 68.3619.1 42.469.8 0.45
(latency, s)
Ro1, n=13; Control, n=17.
doi:10.1371/journal.pone.0030159.t003
Figure 7. Lateral ventricle size is correlated to the latency to find the hidden platform during retention testing. Testing for memory
retention of the location of the hidden platform was performed two weeks following the reversal probe trial. There was a moderate correlation
between the lateral ventricle to brain ratio and the latency to find the hidden platform at 46 days off dox (retention, trial 1), suggesting reduced
memory in Ro1 mice (r
2=0.59; p=0.026).
doi:10.1371/journal.pone.0030159.g007
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hydrocephalus in kaolin-induced hydrocephalus, suggesting the
importance of aquaporin 4 in water clearance in hydrocephalus
[60]. Further studies are necessary to investigate changes in
aquaporin 4 expression and other signaling mediators downstream
of the Ro1 receptor in the development of hydrocephalus in the
Ro1 model.
In sum, the Ro1 model of hydrocephalus represents a novel
model of communicating hydrocephalus. This model has many
similarities to both human hydrocephalus and experimental
models of hydrocephalus. However, the complete penetrance,
inducibility and lack of complicating pathologies in this model
provide the unique opportunity to investigate the etiology and the
pathogenesis of hydrocephalus, which may lead to an understand-
ing of the underlying causes of hydrocephalus. Moreover, because
the Ro1 receptor is a GPCR and is restricted to GFAP-positive
cells, this model enables the investigation of specific signaling
cascades that may cause hydrocephalus, which may lead to the
development of novel drug-based therapeutics to treat this
disorder. The data presented herein provide insight into the
earliest cellular and histological changes in the development and
progression of hydrocephalus, providing a well-characterized
system in which signaling mechanisms involved in the develop-
ment of hydrocephalus can be identified. Additionally, the
behavioral data suggest that treatments that slow the rate of
progression of this disorder may have therapeutic potential by
allowing the brain to compensate and increasing the therapeutic
window for shunt placement or alternative treatments.
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